Clinical Design Technologies Ltd named in Section 216 prohibited-name notice
A Section 216 prohibited-name notice has been filed in relation to Clinical Design Technologies Ltd, registered at 82 St John Street, London EC1M 4JN. Full notice and Companies House record.
Information for general guidance, drawn from the public record. Not legal, financial, or insolvency advice. If you are affected by an insolvency, consult a licensed practitioner or qualified solicitor.
A Section 216 prohibited-name notice relating to Clinical Design Technologies Ltd, registered at 82 St John Street, London EC1M 4JN, was published in the London Gazette on 2 June 2026.
Section 216 of the Insolvency Act 1986 prohibits a director of a company that has entered liquidation from being involved in another company using the same or a similar name for five years, unless one of the statutory exceptions applies. Filing such a notice is one route by which a director can satisfy those exceptions and continue to act lawfully.
The notice
The Gazette notice identifies Clinical Design Technologies Ltd by its registered address at 82 St John Street in the London borough of Islington, within the EC1M postcode. The published notice does not contain further detail about the circumstances of the filing or the individuals involved.
The notice falls within the Gazette category of Moratoria, Prohibited Names and Other: Re-use of a Prohibited Name, and carries notice code 2403.
What Section 216 means
When a company enters insolvent liquidation, its directors face automatic restrictions on reusing its name, or any name so similar as to suggest an association with the failed business. The restriction runs for five years from the date the company went into liquidation. Breaching it is a criminal offence and can expose a director to personal liability for the debts of the new business.
The exceptions are set out in the Insolvency Rules. One is to give notice in the Gazette within 28 days of the liquidation. That notice alerts creditors of the old company that a connected person intends to carry on business under a similar name, giving them the opportunity to take steps to protect their position.
Filing a Section 216 notice does not mean that any wrongdoing has occurred. It is a procedural step that directors take to operate within the rules.
Background
No further information about the liquidation that triggered this notice, the directors involved, or any connected business is available from the published Gazette entry. Companies House records for Clinical Design Technologies Ltd may carry additional detail about the company's officers and filing history.
Common questions
Are you a director of the successor company?
A prohibited-name Gazette notice typically documents one of the three statutory exceptions to Section 216 of the Insolvency Act 1986 (the rule against re-use of a similar name by a former director of a liquidated company). The exception is only valid if the notice meets the timing and content requirements in the relevant Rule. Read more on prohibited names.
Do you trade with the successor company?
A valid notice does not by itself revive the liabilities of the liquidated company. The successor company is a separate legal entity and the directors are personally exposed only if Section 216 is breached.
Sources
- The London Gazette notice (code Moratoria, Prohibited Names and Other: Re-use of a Prohibited Name)
- Editorial standards: how we source and review; five-pass pipeline.
